These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30728912)

  • 41. Correction: Role of novel histone modifications in cancer.
    Shanmugam MK; Arfuso F; Arumugam S; Chinnathambi A; Bian J; Warrier S; Wang LZ; Kumar AP; Ahn KS; Sethi G; Lakshmanan M
    Oncotarget; 2018 Apr; 9(27):19460. PubMed ID: 29722359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction: Molecular response prediction in CML: novel ideas?
    Wolf D; Sopper S
    Oncotarget; 2018 Nov; 9(88):35871. PubMed ID: 30533202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
    Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
    Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway.
    Rahmat MB; Zhang S; Koh CG
    Oncotarget; 2019 Oct; 10(56):5890-5891. PubMed ID: 31645909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction:
    Madic J; Jovelet C; Lopez J; André B; Fatien J; Miran I; Honoré A; Mezquita L; Besse B; Lacroix L; Droniou M
    Oncotarget; 2019 Feb; 10(13):1345. PubMed ID: 30863495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correction: Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan.
    Liang WC; Tian X; Yuo CY; Chen WZ; Kan TM; Su YN; Nishino I; Wong LC; Jong YJ
    PLoS One; 2017; 12(8):e0183406. PubMed ID: 28797072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction: Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
    Morris SM; Subramanian J; Gel ES; Runger GC; Thompson EJ; Mallery DW; Weiss GJ
    PLoS One; 2018; 13(6):e0200224. PubMed ID: 29953541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correction: PCR-Free Enrichment of Mitochondrial DNA from Human Blood and Cell Lines for High Quality Next-Generation DNA Sequencing.
    Gould MP; Bosworth CM; McMahon S; Grandhi S; Grimberg BT; LaFramboise T
    PLoS One; 2016; 11(5):e0156884. PubMed ID: 27243821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.
    Zhang N; Kong L; Shi F; Jing W; Wang H; Yang M; Yu J; Zhu H
    Oncotarget; 2017 Dec; 8(66):110732. PubMed ID: 29300397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction: Exploring Early Micronutrient Deficiencies in Rainbow Trout (Oncorhynchus mykiss) by Next-Generation Sequencing Technology - From Black Box to Functional Genomics.
    Olsvik PA; Hemre GI; Waagbø R
    PLoS One; 2016; 11(5):e0156668. PubMed ID: 27223468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correction: An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer.
    Yu L; Hua X; Yang Y; Li K; Zhang Q; Yu L
    Oncotarget; 2018 Apr; 9(28):20220. PubMed ID: 29733082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction: Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H
    Oncotarget; 2017 Nov; 8(59):100957. PubMed ID: 29243743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin.
    Geagea AG; Rizzo M; Jurjus A; Cappello F; Leone A; Tomasello G; Gracia C; Kattar SA; Massaad-Massade L; Eid A
    Oncotarget; 2019 Nov; 10(60):6538-6539. PubMed ID: 31741717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines
    Salim KY; Vareki SM; Danter WR; San-Marina S; Koropatnick J
    Oncotarget; 2017 Sep; 8(36):60724. PubMed ID: 29062467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
    Guerra B; Martín-Rodríguez P; Díaz-Chico JC; McNaughton-Smith G; Jiménez-Alonso S; Hueso-Falcón I; Montero JC; Blanco R; León J; Rodríguez-González G; Estévez-Braun A; Pandiella A; Díaz-Chico BN; Fernández-Pérez L
    Oncotarget; 2018 Aug; 9(63):32272. PubMed ID: 30181817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correction:
    Guo W; Xu P; Jin T; Wang J; Fan D; Hao Z; Ji Y; Jing S; Han C; Du J; Jiang D; Wen S; Wang J
    Oncotarget; 2018 Apr; 9(28):20221. PubMed ID: 29733083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
    Nivarthi H; Gordziel C; Themanns M; Kramer N; Eberl M; Rabe B; Schlederer M; Rose-John S; Knösel T; Kenner L; Freund P; Aberger F; Han X; Kralovics R; Dolznig H; Jennek S; Friedrich K; Moriggl R
    Oncotarget; 2018 Sep; 9(73):33865. PubMed ID: 30333916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).
    Kim HR; Jang JS; Sun JM; Ahn MJ; Kim DW; Jung I; Lee KH; Kim JH; Lee DH; Kim SW; Cho BC
    Oncotarget; 2017 Aug; 8(33):55766. PubMed ID: 28903459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
    Oncotarget; 2019 Feb; 10(15):1539. PubMed ID: 30863500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correction: MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
    Pu Y; Zhao F; Wang H; Cai W; Gao J; Li Y; Cai S
    Oncotarget; 2017 Sep; 8(36):60723. PubMed ID: 28948006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.